Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta‐analysis of RCTs
Eric M. Ammann, Cole Haskins, Kelsey M. Fillman, et al.
American Journal of Hematology (2016) Vol. 91, Iss. 6, pp. 594-605
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Drugs Associated With Ischemic Stroke
João Pedro Marto, Davide Strambo, Françoise Livio, et al.
Stroke (2021) Vol. 52, Iss. 10
Open Access | Times Cited: 42
A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus
Juan Camilo Santacruz, Marta Juliana Mantilla, I. Rueda, et al.
Cureus (2022)
Open Access | Times Cited: 31
IgG replacement in multiple myeloma
Alex Wonnaparhown, Talal Hilal, Jacqueline D. Squire, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study
Christine Verboon, Bianca van den Berg, David R. Cornblath, et al.
Journal of Neurology Neurosurgery & Psychiatry (2019) Vol. 91, Iss. 2, pp. 113-121
Open Access | Times Cited: 49
Update on diagnosis and treatment of immune thrombocytopenia
Rajeev Sandal, Kundan Mishra, Aditya Jandial, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 553-568
Closed Access | Times Cited: 34
Clinical Practice Updates in the Management Of Immune Thrombocytopenia.
Ayesha Khan, Halina Mydra, A Nevarez
PubMed (2017) Vol. 42, Iss. 12, pp. 756-763
Closed Access | Times Cited: 46
First-Line Therapy for Immune Thrombocytopenia
Siraj Mithoowani, Donald M. Arnold
Hämostaseologie (2019) Vol. 39, Iss. 03, pp. 259-265
Open Access | Times Cited: 36
Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions
Kiran T. Thakur, Arina Tamborska, Greta K. Wood, et al.
Journal of the Neurological Sciences (2021) Vol. 427, pp. 117532-117532
Open Access | Times Cited: 31
The impact of intravenous immunoglobulin on kidney functions and thromboembolic events in dermatology patients
Ceylan Avcı, Aygün Talibova, Özlem Özbağçıvan, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence
Amirhossein Heidari, Amirhossein Shahbazi Mazid, Mohammad Behroozfar, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
Passive Immunization
Danica J. Schulte
Elsevier eBooks (2025), pp. 2707-2738.e15
Closed Access
Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia
B.D. Park, Meet Kumar, Srinivasa R. Nagalla, et al.
Transfusion and Apheresis Science (2018) Vol. 57, Iss. 4, pp. 561-565
Open Access | Times Cited: 31
Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline
Leif G. Hanitsch, Ulrich Baumann, Kaan Boztuğ, et al.
European Journal of Immunology (2020) Vol. 50, Iss. 10, pp. 1432-1446
Open Access | Times Cited: 22
Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta‐analysis
Hilalion Ahn, Jason Tay, Beverley Shea, et al.
Transfusion (2018) Vol. 58, Iss. 10, pp. 2437-2452
Closed Access | Times Cited: 23
Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions
‬‬‬‬Abdulla Watad, Howard Amital, Yehuda Shoenfeld
Lupus (2017) Vol. 26, Iss. 10, pp. 1015-1022
Closed Access | Times Cited: 22
Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases
Taylor Pindi Sala, Jean‐Charles Crave, Martin Duracinský, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 9, pp. 873-881
Closed Access | Times Cited: 20
Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review
John A. Dougherty, Robyn Lupoli Yarsley
Annals of Pharmacotherapy (2020) Vol. 55, Iss. 2, pp. 198-215
Closed Access | Times Cited: 18
Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient’s Activity Level
Katrin Kofler, Anke Strölin, Vanessa Geiger, et al.
Journal of Cutaneous Medicine and Surgery (2021) Vol. 25, Iss. 5, pp. 504-510
Open Access | Times Cited: 15
Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management
Minhee Kim, Luca Borradori, Dédée F. Murrell
Drugs & Aging (2016) Vol. 33, Iss. 10, pp. 711-723
Closed Access | Times Cited: 15
Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis
Binod Dhakal, Lisa Rein, Anikó Szabó, et al.
CHEST Journal (2020) Vol. 158, Iss. 3, pp. 1172-1175
Open Access | Times Cited: 15
Treatment of CIDP
Janev Fehmi, Roberto Bellanti, Siraj Misbah, et al.
Practical Neurology (2022) Vol. 23, Iss. 1, pp. 46-53
Closed Access | Times Cited: 9
Intravenous immunoglobulins for rheumatic disorders and thromboembolic events—a case series and review of the literature
Merav Lidar, Sewar Masarwa, Rotman Pnina, et al.
Immunologic Research (2018) Vol. 66, Iss. 6, pp. 668-674
Closed Access | Times Cited: 14
Renal and hematologic side effects of long‐term intravenous immunoglobulin therapy in patients with neurologic disorders
Aidan Levine, Todd Levine, Kathie Clarke, et al.
Muscle & Nerve (2017) Vol. 56, Iss. 6, pp. 1173-1176
Closed Access | Times Cited: 13
Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review
Ahmed M. Abbas, Yusuf A. Rajabally
Current Drug Safety (2018) Vol. 14, Iss. 1, pp. 3-13
Closed Access | Times Cited: 13
A randomized multicenter study: safety and efficacy of mini‐pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1‐18 years with immune thrombocytopenia
Mohsen Saleh Elalfy, Marwa Reda, Elghamry Islam, et al.
Transfusion (2017) Vol. 57, Iss. 12, pp. 3019-3025
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top